| Financial Year |
March 31 2023 |
| Monetary Funds |
658,986,436.42 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
57,675,085.97 |
| Accounts Receivable |
614,419,794.33 |
| Advances to Suppliers |
268,308,253.35 |
| Other Receivables |
24,178,024.56 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
330,834,676.04 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
26,963,064.28 |
| Total Current Assets |
1,981,365,334.95 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
877,216,569.21 |
| Investment Properties |
-- |
| Fixed Assetes |
191,358,687.92 |
| Under-construction Projects |
464,475.70 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
57,094,064.22 |
| R&D expenses |
103,541,484.50 |
| Goodwill |
1,542,633.71 |
| Long-Term Deferred and Prepaid Expenses |
10,191,110.51 |
| Deferred Income Tax Assets |
12,447,733.77 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
1,328,292,980.52 |
| Total Assets |
3,309,658,315.47 |
| Short-Term Loans |
175,212,819.45 |
| Trading Financial liabilities |
-- |
| Notes Payable |
26,434,175.08 |
| Accounts Payable |
634,371,022.85 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
69,717,979.76 |
| Taxes Payable |
9,138,068.51 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
455,713,439.04 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
11,026,681.91 |
| Other Current Liabilities |
2,911,234.66 |
| Sub-Total of Current Liabilities |
1,409,834,411.16 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
58,560,000.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
7,001,297.44 |
| Deferred Income Tax Liabilities |
1,596,033.98 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
186,839,555.57 |
| Total Liabilities |
1,596,673,966.73 |
| Paid-In Capital(Or Share Stock) |
1,313,708,906.00 |
| Capital Surplus |
6,774,394,285.09 |
| Surplus Reserve |
75,088,648.68 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-7,735,417,990.01 |
| Minority Stockholder's Interest |
1,287,537,847.39 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
425,446,501.35 |
| Owner's Equity（Stockholder's Equity） |
1,712,984,348.74 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,309,658,315.47 |
